Normal levels of serum IGF-I: determinants and validity of current reference ranges

被引:0
作者
G. Brabant
H. Wallaschofski
机构
[1] Christie Hospital,Department of Endocrinology
[2] University of Greifswald,Department of Gastroenterology, Endocrinology and Nutrition
来源
Pituitary | 2007年 / 10卷
关键词
IGF-I; Gender; Age; Genetics; Nutrition; Disease dependency;
D O I
暂无
中图分类号
学科分类号
摘要
Insulin like growth factor I (IGF-I) represents the key marker for the evaluation of Growth hormone (GH) status. As a large number of determinants including age, gender, genetic factors, nutrition, and disease states influence IGF-I serum levels, accurate normative data are essential to translate patient data into diagnostic meaning or even use IGF-I levels for adequate monitoring of patients with an over- or under-active GH axis. Even though reference ranges have been developed in large cohorts of healthy subjects, the dependency of these data on a given assay technology argues for assay specific normative data for IGF-I.
引用
收藏
页码:129 / 133
页数:4
相关论文
共 196 条
  • [1] Giustina A(1998)Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human Endocr Rev 19 717-797
  • [2] Veldhuis JD(2000)GH Research Society J Clin Endocrinol Metab 85 3990-3993
  • [3] Shalet SM(1998)The diagnosis of growth hormone deficiency in children and adults Endocr Rev 19 203-223
  • [4] Toogood A(2003)Insulin-like growth factor-I: marker for diagnosis of acromegaly and monitoring the efficacy of treatment Eur J Endocrinol 148 S15-S20
  • [5] Rahim A(2006)Overview of the IGF-I system Horm Res 65 3-8
  • [6] Brennan BM(1999)The insulin-like growth factor-binding protein (IGFBP) superfamily Endocr Rev 20 761-787
  • [7] Brabant G(2005)Metabolic effects of IGF-I deficiency: lessons from mouse models Pediatr Endocrinol Rev 3 11-19
  • [8] Cohen P(2003)Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study Horm Res 60 53-60
  • [9] Hwa V(2004)Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development J Clin Endocrinol Metab 89 2271-2274
  • [10] Oh Y(2002)Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies Clin Chem 48 2248-2251